Advanced rectal cancer: Delaying surgery not advisable in patients not responding to preoperative CRTOctober 20, 2021GI Oncology
Resection of asymptomatic primary tumor worsens outcomes in nonresectable metastatic CRCOctober 20, 2021GI Oncology
Oncology PracticeDonafenib shows potential as first-line treatment of advanced hepatocellular carcinomaOctober 19, 2021GastroenterologyGI Oncology
Oncology PracticeFew poorly prepped colonoscopies repeated within 1 yearOctober 19, 2021GastroenterologyPreventive CareGI Oncology
Oncology PracticePriming tremelimumab dose regimen shows promising benefit-risk profile in HCCOctober 19, 2021Gastrointestinal CancerGI OncologyGastroenterology
Oncology PracticeLinked-color imaging outperforms other modalities at adenoma detectionOctober 1, 2021GastroenterologyGastrointestinal CancerGI Oncology
Oncology PracticeGastric cancer: Family history–based H. pylori strategy would be cost effectiveSeptember 23, 2021GastroenterologyGI Oncology
Ramucirumab without antihistamine premedication may be feasible in advanced CRCSeptember 18, 2021GI Oncology
Similar long-term outcomes after colorectal surgery in ulcerative colitis-associated vs. sporadic CRCSeptember 18, 2021GI Oncology
SOX+bevacizumab or cetuximab combo offers similar benefits in recurrent advanced CRCSeptember 18, 2021GI Oncology
CRC: COVID-19 lockdown-associated diagnostic delays tied to worse outcomesSeptember 18, 2021GI Oncology
High fasting blood glucose tied to increased CRC risk in patients without diabetesSeptember 18, 2021GI Oncology
Differential CRC risk in Lynch syndrome, Lynch-like syndrome, and familial CRC type XSeptember 18, 2021GI Oncology
